Medicare Enrolled

Dr. Amanda Backlund, M.D.

Family Medicine · Lubbock, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
10709 MILWAUKEE AVE, Lubbock, TX 79424
8067014040
In practice since 2009 (16 years)
NPI: 1114153301 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Backlund from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Backlund? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Backlund

Dr. Amanda Backlund is a family medicine specialist in Lubbock, TX, with 16 years of NPI registration. Based on federal Medicare data, Dr. Backlund performed 1,483 Medicare services across 961 unique beneficiaries.

Between the years covered by Open Payments, Dr. Backlund received a total of $2,059 from 34 pharmaceutical and/or device companies across 144 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Backlund is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ Top 19% volume in TX $2,059 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,483
Medicare services
Top 19% in TX for family medicine
961
Unique beneficiaries
$29
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~93 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
281 $81 $177
Ketorolac injection, per 15 mg
An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg.
168 $0 $18
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
113 $8 $18
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
100 $9 $57
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
98 $1 $14
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
95 $10 $45
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
90 $8 $32
Ceftriaxone antibiotic injection
This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered.
76 $0 $30
Thyroid stimulating hormone (TSH) test
A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function.
69 $16 $71
Lipid panel (cholesterol and triglycerides)
A blood test that measures cholesterol and triglyceride levels.
55 $13 $93
Urinalysis with microscopic exam
A urine test performed manually that includes examining the sample under a microscope to check for abnormalities.
39 $3 $13
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
39 $9 $37
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
37 $121 $301
Vitamin B-12 level test
A blood test that measures the amount of vitamin B-12 in your body.
34 $15 $63
Vitamin D level test
A blood test to measure the amount of Vitamin D-3 in your body.
33 $29 $124
Ferritin level test (iron stores)
A blood test that measures the level of ferritin, a protein that stores iron in the body.
25 $13 $57
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
25 $49 $114
COVID-19 amplified DNA/RNA probe detection
A laboratory test that uses amplified DNA or RNA probes to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) antigen.
20 $50 $160
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
19 $121 $245
Chronic care management, first 20 min/month
This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions.
19 $44 $65
Advance care planning consultation, first 30 min
A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion.
17 $57 $161
Chronic care management services
Comprehensive assessment and care planning for patients requiring ongoing chronic care management.
16 $43 $123
Natriuretic peptide level test
A blood test that measures the level of natriuretic peptide, a protein produced by the heart and blood vessels.
15 $38 $142
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,059
Total received (2018-2024)
Avg $294/year across 7 years
Top 26% in TX for family medicine
34
Companies
144
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,059 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$642
2023
$536
2022
$174
2021
$296
2020
$53
2019
$227
2018
$131

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$347
AbbVie Inc.
$183
PFIZER INC.
$165
Novo Nordisk Inc
$164
Lilly USA, LLC
$148
ABBVIE INC.
$143
Astellas Pharma US Inc
$97
Merck Sharp & Dohme Corporation
$75
AstraZeneca Pharmaceuticals LP
$75
Supernus Pharmaceuticals, Inc.
$73
Otsuka America Pharmaceutical, Inc.
$56
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$51
Tris Pharma Inc
$48
Harmony Biosciences LLC
$42
Abbott Laboratories
$40
Amgen Inc.
$39
Teva Pharmaceuticals USA, Inc.
$30
Bayer HealthCare Pharmaceuticals Inc.
$28
Axsome Therapeutics, Inc.
$20
Sumitomo Pharma America, Inc.
$18
Pharmacosmos Therapeutics Inc.
$18
Acella Pharmaceuticals, LLC
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
Assertio Therapeutics, Inc.
$17
IDORSIA PHARMACEUTICALS US INC
$17
Becton, Dickinson and Company
$16
Kowa Pharmaceuticals America, Inc.
$16
Novartis Pharmaceuticals Corporation
$16
Dexcom, Inc.
$15
E.R. Squibb & Sons, L.L.C.
$15
Allergan, Inc.
$14
Radius Health, Inc.
$13
SANOFI PASTEUR INC.
$12
Takeda Pharmaceuticals U.S.A., Inc.
$12
Top 3 companies account for 33.8% of total payments
Associated products mentioned in payments ›
AJOVY · AREXVY · Auvelity · BEXSERO · Dexcom G6 Transmitter · Dyanavel XR · ELIQUIS · EVENITY · FARXIGA · FLUBLOK QUADRIVALENT · FREESTYLE LIBRE 3 · GEMTESA · Gralise · JANUVIA · Kerendia · LEQVIO · Livalo · MONOFERRIC · MOUNJARO · MYRBETRIQ · NP Thyroid 60 · NUEDEXTA · NURTEC ODT · OXTELLAR XR · Ozempic · PAXLOVID · PREVNAR 20 · Prolia · QULIPTA · QUVIVIQ · REXULTI · ROTATEQ · Rybelsus · SHINGRIX · SYNJARDY · Saxenda · TRELEGY ELLIPTA · TROKENDI XR · Tymlos · UBRELVY · VIBERZI · VRAYLAR · VYVANSE · Veozah · WAKIX · Wegovy · XIFAXAN · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $139 per 100 Medicare services performed
Looking for a family medicine specialist in Lubbock?
Compare family medicine physicians in the Lubbock area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
111
Per 100K population
35.3
County median income
$63,367
Nearest hospital
EXCEPTIONAL COMMUNITY HOSPITAL LUBBOCK
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Backlund is a clinical cardiology specialist, with above-average Medicare volume (top 19% in TX), with low-engagement industry engagement, with 16 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Backlund experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Backlund performed 281 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Backlund receive payments from pharmaceutical companies?
Yes. Dr. Backlund received a total of $2,059 from 34 companies across 144 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Backlund's costs compare to other family medicine physicians in Lubbock?
Dr. Backlund's average Medicare payment per service is $29. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Backlund) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →